Sector valuations Vertex Pharmaceuticals Incorporated

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/04/2026 BST			5-day change	1st Jan Change
436.27 ^USD	-2.35%		-0.56%	-3.77%

04-10	RBC Trims Price Target on Vertex Pharmaceuticals to $541 From $543, Keeps Outperform Rating	MT
04-09	Evercore ISI Adjusts Vertex Pharmaceuticals PT to $535 From $530, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	25.48x	5.01x	1.76x	7.69x	17.17x	17.84x	-.--%	114B
ELI LILLY AND COMPANY	28.06x	17.34x	0.58x	10.65x	21.34x	22.69x	0.7%	855B
JOHNSON & JOHNSON	25.57x	6.7x	-1.77x	5.96x	16.25x	17.92x	2.19%	581B
ABBVIE INC.	23.6x	67.62x	0.08x	6.37x	12.59x	13.21x	3.26%	376B
ASTRAZENECA PLC	25.82x	5.81x	1.21x	5.33x	14.91x	15.97x	1.62%	318B
MERCK & CO., INC.	28.52x	5.36x	-0.7x	5.05x	15.83x	18.67x	2.75%	303B
NOVARTIS AG	21.36x	6.43x	51.35x	5.74x	13.89x	15.19x	2.85%	295B
AMGEN INC.	23.73x	16.16x	4.47x	6.14x	10.92x	13.92x	2.83%	192B
GILEAD SCIENCES, INC.	19.57x	6.41x	2.77x	5.99x	10.84x	12.76x	2.29%	176B
NOVO NORDISK A/S	11.45x	4.81x	-1.18x	4.09x	8.6x	10.1x	4.5%	165B
PFIZER INC.	12.33x	1.7x	0.2x	3.25x	7.83x	9.17x	6.45%	155B
BRISTOL-MYERS SQUIBB COMPANY	11.89x	5.14x	0.27x	3.16x	8.35x	9.1x	4.24%	121B
GSK PLC	13.62x	4.48x	1.07x	2.9x	8.41x	9.6x	3.22%	116B
SANOFI	11.87x	1.26x	1.83x	2.33x	7.48x	8.28x	5.26%	114B
CHUGAI PHARMACEUTICAL CO., LTD.	28.55x	6.36x	1.73x	9.78x	18.39x	19.23x	1.56%	90.74B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.07x	1.29x	0.82x	2.9x	10.7x	30.37x	3.44%	57.78B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	40.42x	5.44x	2.08x	9.2x	30.69x	32.01x	0.47%	55.23B
BAYER AG	20.15x	1.42x	-0.13x	1.59x	7.62x	13.05x	0.55%	46.49B
Average	23.56x	9.37x	3.69x	5.45x	13.43x	16.06x	2.68%	229.56B
Weighted average by Cap.	23.89x	13.95x	4.09x	6.48x	14.96x	16.72x	2.39%